Featured Research

from universities, journals, and other organizations

Scientists Develop Potential New Epilepsy Drug

Date:
June 15, 2006
Source:
The Hebrew University of Jerusalem
Summary:
New and safer compounds for treatment of epilepsy patients and those suffering from other neural disorders have been developed by researchers at the Hebrew University of Jerusalem School of Pharmacy.

Professors Meir Bialer (left) and Boris Yagen of the Hebrew University of Jerusalem School of Pharmacy.
Credit: Hebrew University Photo by Sasson Tiram

New and safer compounds for treatment of epilepsy patients and those suffering from other neural disorders have been developed by researchers at the Hebrew University of Jerusalem School of Pharmacy.

Related Articles


For their groundbreaking work, Professors Meir Bialer and Boris Yagen of the Department of Pharmaceutics and Medicinal Chemistry and Natural Products at the School of Pharmacy have been named among the winners of the Kaye Innovation Awards to be presented on June 13 at the 69th meeting of the Hebrew University Board of Governors.

Professors Bialer and Yagen have succeeded in developing a potential alternative for valproic acid (VPA), one of the leading antiepileptic drugs, which has been used as a central nervous system (CNS) treatment since 1967. However, that drug also has serious safety drawbacks, with side effects that can cause damage especially to children or women of child-brearing potential.

In their experimental search for an alternative to VPA, Professors Bialer and Yagen have developed propylisopropyl acetamide (PID), a new antiepileptic and CNS drug that has demonstrated excellent antiepileptic and antiallodynic (against neuropathic pain) activities, without the damaging side effects of VPA.

Patents for PID variations developed by the two scientists have been obtained by Yissum, the Hebrew University's technology transfer company. In June 2005, Jazz Pharmaceuticals of Palo Alto, California, and The Epilepsy Therapy Development Project (TETDP) of Reston, Virginia, awarded a grant, through Yissum, to the Hebrew University researchers to do further evaluation work As an integral part of this grant, Jazz Pharmaceuticals signed a licensing agreement with Yissum for developing a new antiepileptic and CNS drug, based on the PID compounds developed at the university.

The potential commercial applications of these compounds are believed to be highly promising, providing a second-generation drug alternative for those currently unable to be treated with VPA.

The Kaye Innovation Awards have been given annually since 1994. Isaac Kaye of England, a prominent industrialist in the pharmaceutical industry, established the awards to encourage faculty, staff, and students of the Hebrew University to develop innovative methods and inventions with good commercial potential which will benefit the university and society.


Story Source:

The above story is based on materials provided by The Hebrew University of Jerusalem. Note: Materials may be edited for content and length.


Cite This Page:

The Hebrew University of Jerusalem. "Scientists Develop Potential New Epilepsy Drug." ScienceDaily. ScienceDaily, 15 June 2006. <www.sciencedaily.com/releases/2006/06/060613082350.htm>.
The Hebrew University of Jerusalem. (2006, June 15). Scientists Develop Potential New Epilepsy Drug. ScienceDaily. Retrieved March 5, 2015 from www.sciencedaily.com/releases/2006/06/060613082350.htm
The Hebrew University of Jerusalem. "Scientists Develop Potential New Epilepsy Drug." ScienceDaily. www.sciencedaily.com/releases/2006/06/060613082350.htm (accessed March 5, 2015).

Share This


More From ScienceDaily



More Health & Medicine News

Thursday, March 5, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Bupa Eyes India Healthcare Opportunities

Bupa Eyes India Healthcare Opportunities

Reuters - Business Video Online (Mar. 5, 2015) Bupa is hoping to expand in India&apos;s fast-growing health insurance market, once a rule change on foreign investment is implemented. The British private healthcare group&apos;s CEO tells Grace Pascoe why it&apos;s so keen on the new opportunity. Video provided by Reuters
Powered by NewsLook.com
Doctor in Your Pocket Is Getting Smarter

Doctor in Your Pocket Is Getting Smarter

Reuters - Business Video Online (Mar. 5, 2015) Mobile apps are turning smartphones into a personal doctors, with users able to measure heart rate, blood pressure and even blood sugar. But will it change our behaviour? Ivor Bennett reports from the Mobile World Congress in Barcelona. Video provided by Reuters
Powered by NewsLook.com
AbbVie Inks $21B Deal To Buy Cancer Drugmaker Pharmacyclics

AbbVie Inks $21B Deal To Buy Cancer Drugmaker Pharmacyclics

Newsy (Mar. 5, 2015) AbbVie announced Wednesday it will buy cancer drugmaker Pharmacyclics in a $21 billion deal. Video provided by Newsy
Powered by NewsLook.com
Adults Only Get The Flu Twice A Decade, Researchers Say

Adults Only Get The Flu Twice A Decade, Researchers Say

Newsy (Mar. 4, 2015) Researchers found adults only get the flu about once every five years. Scientists analyzed how a person&apos;s immunity builds up over time as well. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins